PHARMADVICE
ActiveSummary
PHARMADVICE has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.21M and a net result of €-12k. Equity remains stable across the filed fiscal years (±1.7% per year). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability68▲+2
Solvency100=
Growth58=
Track record100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €90k at 30 days acceptable
Liquidity ample (current ratio 16.34 against 15.66 in 2024; short-term debt: 1% and cash: 14.1% of total assets), and 1.1% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
98.9%
Return on assets
-1%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 14-01-2026, 17 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
17 d early
2024
16 d early
2023
2 d early
2022
1 d early
2021
5 d early
2020
5 d early
2019
3 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close25-09-2026 today31-01-2027 deadline
History
Financials · fiscal year 2025, micro schema
Equity
€1.21M▼ 1.0%
2024 · €1.22M
Total assets
€1.22M▼ 0.9%
2024 · €1.24M
Net result
€-12k▲ 50.3%
2024 · €-25k
Working capital
€194k▲ 11.3%
2024 · €174k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€-32k▼ 13.3%€-25k▲ 21.2%€-8k▲ 67.4%€-25k▼ 202%€-13k▲ 48.9%
Net result€-32k▼ 18.8%€-25k▲ 21.1%€-8k▲ 67.2%€-25k▼ 195%€-12k▲ 50.3%
Equity€1.28M▼ 2.5%€1.26M▼ 2.0%€1.25M▼ 0.7%€1.22M▼ 2.0%€1.21M▼ 1.0%
Total assets€1.29M▼ 4.1%€1.27M▼ 1.9%€1.26M▼ 0.5%€1.24M▼ 1.9%€1.22M▼ 0.9%
Debt€10k▼ 69.8%€11k▲ 7.9%€13k▲ 18.7%€13k▲ 1.7%€14k▲ 7.8%
Working capital€123k▲ 6.1%€137k▲ 11.3%€166k▲ 21.2%€174k▲ 4.9%€194k▲ 11.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €13k in 2025 against €25k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.22M
Fixed assets
€1.02M ▼ 3.0%
Current assets
€206k ▲ 11.0%
Equity and liabilities €1.22M
Equity
€1.21M ▼ 1.0%
Debt
€14k ▲ 7.8%
Debt's share of the balance-sheet total rises from 1.0% to 1.1%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€19k▲
2024 · €7k
Cash flow
€19k▲
2024 · €7k
Current ratio
16.34▲
2024 · 15.66
Debt to equity
0.01▲
2024 · 0.01
ROE
-1.0%▲
2024 · -2.0%
ROA
-1.0%▲
2024 · -2.0%
Interest coverage
118.72▲
2024 · 93.47
Debt ≤ 1 year
€13k▲
2024 · €12k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €6k | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €39k | €39k | €37k | €32k | €32k | = |
| Other operating charges640/8 | - | €6k | €5k | €5k | €5k | ▲ 2.9% |
| Gross operating margin9900 | €12k | €20k | €34k | €12k | €24k | ▲ 103% |
| Operating profit (loss)9901 | €-32k | €-25k | €-8k | €-25k | €-13k | ▲ 48.9% |
| Financial income75/76B | - | €9 | €5 | €308 | €625 | ▲ 103% |
| Recurring financial income75 | €98 | €9 | €5 | €308 | €625 | ▲ 103% |
| Financial charges65/66B | - | €110 | €112 | €73 | €160 | ▲ 118% |
| Recurring financial charges65 | €115 | €110 | €112 | €73 | €160 | ▲ 118% |
| Profit (loss) for the period before taxes9903 | €-32k | €-25k | €-8k | €-25k | €-12k | ▲ 50.3% |
| Income taxes67/77 | €105 | €31 | - | - | - | - |
| Profit (loss) for the period9904 | €-32k | €-25k | €-8k | €-25k | €-12k | ▲ 50.3% |
| Profit (loss) for the period to be appropriated9905 | €-32k | €-25k | €-8k | €-25k | €-12k | ▲ 50.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.29M | €1.27M | €1.26M | €1.24M | €1.22M | ▼ 0.9% |
| Fixed assets21/28 | €1.16M | €1.12M | €1.08M | €1.05M | €1.02M | ▼ 3.0% |
| Tangible fixed assets22/27 | €1.16M | €1.12M | €1.08M | €1.05M | €1.02M | ▼ 3.0% |
| Land and buildings22 | - | €1.11M | €1.08M | €1.05M | €1.02M | ▼ 3.0% |
| Furniture and vehicles24 | - | €4k | - | - | - | - |
| Current assets29/58 | €133k | €148k | €179k | €186k | €206k | ▲ 11.0% |
| Amounts receivable within one year40/41 | €4k | €5k | €3k | €3k | €4k | ▲ 21.0% |
| Trade receivables40 | - | €3k | - | - | - | - |
| Other amounts receivable41 | - | €3k | €3k | €3k | €4k | ▲ 21.0% |
| Current investments50/53 | - | - | - | - | €30k | - |
| Cash at bank and in hand54/58 | €128k | €142k | €174k | €183k | €173k | ▼ 5.5% |
| Deferred charges and accrued income490/1 | - | - | €2k | €0 | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.29M | €1.27M | €1.26M | €1.24M | €1.22M | ▼ 0.9% |
| Equity10/15 | €1.28M | €1.26M | €1.25M | €1.22M | €1.21M | ▼ 1.0% |
| Contributions10/11 | - | €1.44M | €1.44M | €1.44M | €1.44M | = |
| Reserves13 | €148k | €148k | €148k | €148k | €148k | = |
| Non-distributable reserves130/1 | - | €144k | €144k | €0 | - | - |
| Reserves not available under the articles1311 | - | €144k | €144k | €0 | - | - |
| Distributable reserves133 | - | €4k | €4k | €148k | €148k | = |
| Profit (loss) carried forward14 | €-307k | €-332k | €-340k | €-365k | €-377k | ▼ 3.4% |
| Amounts payable17/49 | €10k | €11k | €13k | €13k | €14k | ▲ 7.8% |
| Amounts payable within one year42/48 | €10k | €11k | €13k | €12k | €13k | ▲ 6.4% |
| Trade debts44 | €1k | €2k | €4k | €3k | €3k | ▲ 14.5% |
| Suppliers440/4 | - | €2k | €4k | €3k | €3k | ▲ 14.5% |
| Taxes, remuneration and social security45 | - | €30 | - | - | - | - |
| Taxes450/3 | - | €30 | - | - | - | - |
| Other amounts payable47/48 | - | €8k | €9k | €9k | €9k | ▲ 3.7% |
| Accrued charges and deferred income492/3 | - | - | - | €1k | €1k | ▲ 23.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €-32k | €-25k | €-8k | €-25k | €-12k | ▲ 50.3% |
| + Depreciation and write-downs630 | €39k | €39k | €37k | €32k | €32k | = |
| Operating cash flow (approximation) | €7k | €14k | €29k | €7k | €19k | ▲ 175% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | €14k | €32k | €9k | €-10k | ▼ 217% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
15-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
29-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
26-01
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
Financial
Liquidity triplescurrent ratio 13.39
Current ratio from 4.52 to 13.39; short-term debt falls from €33k to €10k.
26-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Liquidity quadruplescurrent ratio 4.52
Current ratio from 1.08 to 4.52; short-term debt falls from €1.38M to €33k.
28-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
24-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
27-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 8 acts read
About the unread acts
We know of 8 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
8 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2008
Ground area
2,369 m²
Building footprint
501 m²
Volume, LiDAR
28,217 m³
Parcel 24432D0158/00K000, Flanders · tallest building 58.8 m, ±19 floors. Linked by address, not a title deed.
18
companies at this address
See who is registered here
1 establishment unit
Pharmadvice
since 20082.169.873.469
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24432D0158/00K000 | Flanders | 2,369 m² | 1 · 501 m² | 58.8 m · 19 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Identification & contact
Identification
Legal formPrivate limited company
Founded12-02-2008
Fiscal year end30-06
Scores and ratios are computed by Checked and are not a credit decision.